Biologics

Spinal Implants

Xtant Medical to Issue Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

BELGRADE, Mont. , March 03, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and